Viral bimolecular fluorescence complementation: A novel tool to study intracellular vesicular trafficking pathways

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Dirk, Brennan S ^a   Jacob, Rajesh Abraham ^a   Johnson, Aaron L ^a   Pawlak, Emily N ^a   Cavanagh, P Craig ^a   Van Nynatten, Logan ^a   Haeryfar, S M Mansour ^a   Dikeakos, Jimmy D ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; NEF PROTEIN; PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1; SORTING NEXIN 18; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; PACS1 PROTEIN, HUMAN; SNX18 PROTEIN, HUMAN; SORTING NEXIN; VESICULAR TRANSPORT PROTEIN;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; EXPRESSION VECTOR; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRAL BIMOLECULAR FLUORESCENCE COMPLEMENTATION; VIRUS REPLICATION; FLUORESCENCE; GENE; HEK293 CELL LINE; HELA CELL LINE; JURKAT CELL LINE; LENTIVIRINAE; PHYSIOLOGY; PROTEIN TRANSPORT; TRANSPORT VESICLE; VIROLOGY; VIRUS DNA CELL DNA INTERACTION; WESTERN BLOTTING;

FOOT-AND-MOUTH DISEASE VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

BLOTTING, WESTERN; FLOW CYTOMETRY; FLUORESCENCE; GENES, MHC CLASS I; HEK293 CELLS; HELA CELLS; HIV-1; HUMANS; JURKAT CELLS; LENTIVIRUS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN TRANSPORT; SORTING NEXINS; TRANSCRIPTION FACTOR AP-1; TRANSPORT VESICLES; VESICULAR TRANSPORT PROTEINS; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 84928485439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125619     Document Type: Article

References (58)

1. Pfeffer SR. Entry at the trans-face of the Golgi. Cold Spring Harb Perspect Biol. 2011; 3(3). Epub 2011/03/23. cshperspect.a005272 [pii] doi: 10.1101/cshperspect.a005272 PMID: 21421921; PubMed Central PMCID: PMC3039930.
2. Bonifacino JS, Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol. 2006; 7(8):568-79. Epub 2006/08/29. nrm1985 [pii] doi: 10.1038/nrm1985 PMID: 16936697.
3. Frankel AD, Young JA. HIV-1: fifteen proteins and an RNA. Annu Rev Biochem. 1998; 67:1-25. Epub 1998/10/06. doi: 10.1146/annurev.biochem.67.1.1 PMID: 9759480.
4. Swanson CM, Malim MH. SnapShot: HIV-1 proteins. Cell. 2008; 133(4):742, e1. Epub 2008/05/20.S0092-8674(08)00569-2 [pii] doi: 10.1016/j.cell.2008.05.005 PMID: 18485880.
5. Kestler HW 3rd, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 1991; 65(4):651-62. Epub 1991/05/17. 0092-8674(91)90097-I [pii]. PMID: 2032289.
6. Fackler OT, Baur AS. Live and let die: Nef functions beyond HIV replication. Immunity. 2002; 16 (4):493-7. Epub 2002/04/24. S1074761302003072 [pii]. PMID: 11970873.
7. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell. 2002; 111(6):853-66. Epub 2003/01/16. S0092867402011625 [pii]. PMID: 12526811.
8. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 1998; 391(6665):397-401. Epub 1998/02/05. doi: 10.1038/34929 PMID: 9450757.
9. Dikeakos JD, Thomas L, Kwon G, Elferich J, Shinde U, Thomas G. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I. Mol Biol Cell. 2012; 23(11):2184-97. Epub 2012/04/13. mbc.E11-11-0928 [pii] doi: 10.1091/mbc.E11-11-0928 PMID: 22496420; PubMed Central PMCID: PMC3364181.
10. Hung CH, Thomas L, Ruby CE, Atkins KM, Morris NP, Knight ZA, et al. HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I. Cell Host Microbe. 2007; 1 (2):121-33. Epub 2007/11/17. S1931-3128(07)00043-1 [pii] doi: 10.1016/j.chom.2007.03.004 PMID: 18005690.
11. Renkema GH, Saksela K. Interactions of HIV-1 NEF with cellular signal transducing proteins. Front Biosci. 2000; 5:D268-83. Epub 2000/03/07. PMID: 10704155.
12. Pawlak EN, Dikeakos JD. HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion. Biochim Biophys Acta. 2015; 1850(4):733-41. Epub 2015/01/15. doi: 10.1016/j.bbagen.2015.01.003 PMID: 25585010.
13. Dikeakos JD, Atkins KM, Thomas L, Emert-Sedlak L, Byeon IJ, Jung J, et al. Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol Biol Cell. 2010; 21(19):3279-92. Epub 2010/08/13. E10-05-0470 [pii] doi: 10.1091/mbc.E10-05-0470 PMID: 20702582; PubMed Central PMCID: PMC2947465.
14. Jia X, Singh R, Homann S, Yang H, Guatelli J, Xiong Y. Structural basis of evasion of cellular adaptive immunity by HIV-1 Nef. Nat Struct Mol Biol. 2012; 19(7):701-6. Epub 2012/06/19. nsmb.2328 [pii] doi: 0.1038/nsmb.2328 PMID: 22705789.
15. Kerppola TK. Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells. Annu Rev Biophys. 2008; 37:465-87. Epub 2008/06/25. doi: 10.1146/annurev.biophys.37.032807.125842 PMID: 18573091; PubMed Central PMCID: PMC2829326.
16. Kerppola TK. Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol. 2006; 7(6):449-56. Epub 2006/04/21. nrm1929 [pii] doi: 10.1038/nrm1929 PMID: 16625152; PubMed Central PMCID: PMC2512262.
17. Kerppola TK. Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells. Nat Protoc. 2006; 1(3):1278-86. Epub 2007/04/05. nprot.2006.201 [pii] doi: 10.1038/nprot.2006.201 PMID: 17406412; PubMed Central PMCID: PMC2518326.
18. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001; 7(1):33-40. Epub 2001/01/03. doi: 10.1038/83324 PMID: 11135613.
19. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986; 59(2):284-91. Epub 1986/08/01. PMID: 3016298; PubMed Central PMCID: PMC253077.
20. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, et al. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol. 2002; 13(7):1806-15. Epub 2002/06/29. PMID: 12089376.
21. Ryan MD, King AM, Thomas GP. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J Gen Virol. 1991; 72 (Pt 11):2727-32. Epub 1991/11/01. PMID: 1658199.
22. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, et al. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol. 2001; 82(Pt 5):1013-25. Epub 2001/04/12. PMID: 11297676.
23. Szymczak AL, Vignali DA. Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin Biol Ther. 2005; 5(5):627-38. Epub 2005/06/07. doi: 10.1517/14712598.5.5.627 PMID: 15934839.
24. Bryksin AV, Matsumura I. Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids. Biotechniques. 2010; 48(6):463-5. Epub 2010/06/24. 000113418 [pii] doi: 10.2144/000113418 PMID: 20569222; PubMed Central PMCID: PMC3121328.
25. Nam HS, Benezra R. High levels of Id1 expression define B1 type adult neural stem cells. Cell Stem Cell. 2009; 5(5):515-26. Epub 2009/11/10. S1934-5909(09)00401-9 [pii] doi: 10.1016/j.stem.2009.08.017 PMID: 19896442; PubMed Central PMCID: PMC2775820.
26. Carlotti F, Bazuine M, Kekarainen T, Seppen J, Pognonec P, Maassen JA, et al. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Mol Ther. 2004; 9(2):209-17. Epub 2004/02/05. 10.1016/j.ymthe.2003.11.021 S1525001603003939 [pii]. PMID: 14759805.
27. Cordelieres FP, Bolte S. Experimenters' guide to colocalization studies: finding a way through indicators and quantifiers, in practice. Methods in cell biology. 2014; 123:395-408. doi: 10.1016/B978-0-12-420138-5.00021-5 PMID: 24974039.
28. Benson RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med. 1993; 177 (6):1561-6. Epub 1993/06/01. PMID: 8098729.
29. Cai CY, Zhang X, Sinko PJ, Burakoff SJ, Jin YJ. Two sorting motifs, a ubiquitination motif and a tyrosine motif, are involved in HIV-1 and simian immunodeficiency virus Nef-mediated receptor endocytosis. J Immunol. 2011; 186(10):5807-14. Epub 2011/04/13. jimmunol.1003506 [pii] doi: 10.4049/jimmunol.1003506 PMID: 21482738.
30. Chaudhry A, Verghese DA, Das SR, Jameel S, George A, Bal V, et al. HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J Immunol. 2009; 183(4):2415-24. Epub 2009/07/22. jimmunol.0804014 [pii] doi: 10.4049/jimmunol.0804014 PMID: 19620308.
31. Leonard JA, Filzen T, Carter CC, Schaefer M, Collins KL. HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements. J Virol. 2011; 85(14):6867-81. Epub 2011/05/06. JVI.00229-11 [pii] doi: 10.1128/JVI.00229-11 PMID: 21543478; PubMed Central PMCID: PMC3126561.
32. Saksela K, Cheng G, Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 1995; 14(3):484-91. Epub 1995/02/01. PMID: 7859737; PubMed Central PMCID: PMC398106.
33. Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S, et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med. 2001; 7(11):1217-24. Epub 2001/11/02. 10.1038/nm1101-1217 nm1101-1217 [pii]. PMID: 11689886.
34. Mukerji J, Olivieri KC, Misra V, Agopian KA, Gabuzda D. Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology. 2012; 9:33. Epub 2012/04/27. 1742-4690-9-33 [pii] doi: 10.1186/1742-4690-9-33 PMID: 22534017; PubMed Central PMCID: PMC3382630.
35. Banning C, Votteler J, Hoffmann D, Koppensteiner H, Warmer M, Reimer R, et al. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS One. 2010; 5(2):e9344. Epub 2010/02/25. doi: 10.1371/journal.pone.0009344 PMID: 20179761; PubMed Central PMCID: PMC2825263.
36. Donnelly ML, Hughes LE, Luke G, Mendoza H, ten Dam E, Gani D, et al. The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol. 2001; 82(Pt 5):1027-41. Epub 2001/04/12. PMID: 11297677.
37. Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, et al. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol. 2004; 22(5):589-94. Epub 2004/04/06. 10.1038/nbt957 nbt957 [pii]. PMID: 15064769.
38. Roeth JF, Collins KL. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev. 2006; 70(2):548-63. Epub 2006/06/09. 70/2/548 [pii] doi: 10.1128/MMBR.00042-05 PMID: 16760313; PubMed Central PMCID: PMC1489538.
39. Youker RT, Shinde U, Day R, Thomas G. At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis. Biochem J. 2009; 421(1):1-15. Epub 2009/06/10.BJ20081016 [pii] doi: 10.1042/BJ20081016 PMID: 19505291.
40. Haberg K, Lundmark R, Carlsson SR. SNX18 is an SNX9 paralog that acts as a membrane tubulator in AP-1-positive endosomal trafficking. J Cell Sci. 2008; 121(Pt 9):1495-505. Epub 2008/04/16.jcs.028530 [pii] doi: 10.1242/jcs.028530 PMID: 18411244.
41. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell. 1998; 95(2):163-75. PMID: 9790524.
42. Kafri T. Gene delivery by lentivirus vectors an overview. Methods Mol Biol. 2004; 246:367-90. Epub 2004/02/19. 1-59259-650-9:367 [pii]. PMID: 14970605.
43. Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol. 2007; 36(3):184-204. Epub 2007/09/18. MB:36:3:184 [pii]. PMID: 17873406.
44. Martinez-Salas E. Internal ribosome entry site biology and its use in expression vectors. Curr Opin Biotechnol. 1999; 10(5):458-64. Epub 1999/10/06. S0958-1669(99)00010-5 [pii]. PMID: 10508627.
45. Borman AM, Le Mercier P, Girard M, Kean KM. Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res. 1997; 25(5):925-32. Epub 1997/03/01. gka191 [pii]. PMID: 9023100; PubMed Central PMCID: PMC146526.
46. Roberts LO, Seamons RA, Belsham GJ. Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins. RNA. 1998; 4(5):520-9. Epub 1998/05/15. PMID: 9582094; PubMed Central PMCID: PMC1369636.
47. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther. 2000; 1 (4):376-82. Epub 2000/08/10. 10.1006/mthe.2000.0050 S1525-0016(00)90050-9 [pii]. PMID: 10933956.
48. Hennecke M, Kwissa M, Metzger K, Oumard A, Kroger A, Schirmbeck R, et al. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res. 2001; 29(16):3327-34. Epub 2001/08/16. PMID: 11504870; PubMed Central PMCID: PMC55851.
49. Kim JH, Lee SR, Li LH, Park HJ, Park JH, Lee KY, et al. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One. 2011; 6(4): e18556. Epub 2011/05/24. 10.1371/journal.pone.0018556 PONE-D-11-01024 [pii]. PMID: 21602908; PubMed Central PMCID: PMC3084703. doi: 10.1371/journal.pone.0018556
50. Ryan MD, Drew J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J. 1994; 13(4):928-33. Epub 1994/02/15. PMID: 8112307; PubMed Central PMCID: PMC394894.
51. Poe JA, Smithgall TE. HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication. J Mol Biol. 2009; 394(2):329-42. Epub 2009/09/29. S0022-2836(09)01174-7 [pii] doi: 10.1016/j.jmb.2009.09.047 PMID: 19781555; PubMed Central PMCID: PMC2783173.
52. Poe JA, Vollmer L, Vogt A, Smithgall TE. Development and validation of a high-content bimolecular fluorescence complementation assay for small-molecule inhibitors of HIV-1 Nef dimerization. J Biomol Screen. 2014; 19(4):556-65. Epub 2013/11/28. 1087057113513640 [pii] doi: 10.1177/1087057113513640 PMID: 24282155.
53. Ye H, Choi HJ, Poe J, Smithgall TE. Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck. Biochemistry. 2004; 43(50):15775-84. Epub 2004/12/15. doi: 10.1021/bi048712f PMID: 15595833.
54. Schaefer MR, Wonderlich ER, Roeth JF, Leonard JA, Collins KL. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS Pathog. 2008; 4(8): e1000131. Epub 2008/08/30. doi: 10.1371/journal.ppat.1000131 PMID: 18725938.
55. Roeth JF, Williams M, Kasper MR, Filzen TM, Collins KL. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J Cell Biol. 2004; 167(5):903-13. Epub 2004/12/01.jcb.200407031 [pii] doi: 10.1083/jcb.200407031 PMID: 15569716.
56. Emert-Sedlak L, Kodama T, Lerner EC, Dai W, Foster C, Day BW, et al. Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds. ACS Chem Biol. 2009; 4(11):939-47. Epub 2009/10/08. doi: 10.1021/cb900195c PMID: 19807124.
57. Manjunath N, Wu H, Subramanya S, Shankar P. Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev. 2009; 61(9):732-45. Epub 2009/04/04. S0169-409X(09)00060-X [pii] doi: 10.1016/j.addr.2009.03.004 PMID: 19341774; PubMed Central PMCID: PMC2789654.
58. Singer O, Verma IM. Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr Gene Ther. 2008; 8(6):483-8. Epub 2008/12/17. PMID: 19075631; PubMed Central PMCID: PMC2774780.